The burden of migraine in Europe
24.10.2018
Question for written answer E-005437-18
to the Commission
Rule 130
Vilija Blinkevičiūtė (S&D)
Migraine is a distinct neurological disease characterised by pain, nausea and increased sensitivity to light and sound.
Migraine can be very debilitating, leading to a significant reduction in quality of life for those living with the condition, including the ability to work or engage in family and social activities. This may lead to depression and other mental health conditions. Migraine is also associated with a high disease burden, and has a considerable economic impact on healthcare systems and society. In Europe, it is estimated that the direct and indirect costs of migraine amount to EUR 27 billion per year, much of which arises from lost work days.
In spite of all this, migraine is not listed among the diseases covered by the Commission in its approach to non-communicable diseases (NCDs), nor is it being addressed properly when it comes to employment and workplace policies. In light of the societal and economic impact of migraine:
- 1.Does the Commission agree that migraine should be considered as a serious neurodegenerative disease?
- 2.Can the Commission indicate whether it will take action to include migraine in its actions on NCDs?
- 3.Can the Commission indicate whether it intends to promote employment policies that take into account the needs of people living with migraine?